# Safety and Tolerability of the Vaginal Gel PRO 2000/5

> **NCT00006207** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** PRO 2000

## Key facts

- **NCT ID:** NCT00006207
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006207, "Safety and Tolerability of the Vaginal Gel PRO 2000/5". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00006207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*